Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An ongoing debate exists over the role of percutaneous coronary intervention and coronary artery bypass grafting for revascularization in patients with multivessel or left main disease. Despite improvements in stent technology, bypass surgery still provides the best long-term results in the majority of patients. The present review focuses on randomized controlled trials and a meta-analysis published over the last 4 years.

Original publication

DOI

10.1053/j.semtcvs.2019.08.009

Type

Journal article

Journal

Semin Thorac Cardiovasc Surg

Publication Date

20/08/2019

Keywords

Coronary artery bypass grafting, Meta-analysis, Myocardial revascularization, Percutaneous coronary intervention, Randomized controlled trials